Skip to Late-Breaking Abstracts »

All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).

Abstract Titles

Poster Presentation Dates

All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.

Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.

Search word or phrase:

# Type Title Authors Category Keywords
212 Poster Presentation CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and synergizing with tumor-targeted antibodies. Vanessa Gauttier; Marion Drouin; Sabrina Pengam; Javier Saenz; Bérangère Evrard; Caroline Mary; Géraldine Teppaz; Ariane Desselle; Virginie Thépénier; Emmanuelle Wilhelm; Elise Chiffoleau; Nicolas Poirier, PhD; Checkpoint Blockade Therapy Checkpoint blockade; Dendritic cell; Myeloid cells; Tumor microenvironment